AttendMe Owl Logo
AttendMe
Evidence Evolution
Colorectal SurgeryColorectal Surgery

How This Evidence Evolved

Watch-and-Wait in Rectal Cancer

Organ Preservation Following Complete Clinical Response to Neoadjuvant Therapy

22.2

Timeline

Signal

Early observations and pilot data that first suggested a new direction

Habr-Gama and colleagues studied 265 patients with resectable distal rectal adenocarcinoma treated with neoadjuvant chemoradiation. Complete clinical response occurred in 71 patients (26.8%), who received nonoperative treatment. Their mean follow-up was 57.3 months, with 2 endorectal and 3 systemic recurrences. Five-year overall and disease-free survival were 100% and 92% in the observation group, versus 88% and 83% in the resected pathological complete-response group. This selected, nonrandomized comparison supported further study of organ preservation.
Proof

Landmark RCTs and pivotal trials that established the evidence base

The 2018 International Watch & Wait Database (IWWD) report identified 1,009 registered patients from 47 institutions in 15 countries; its outcome analysis included 880 complete clinical responders. Local regrowth occurred predominantly within two years and in the bowel wall, emphasizing endoscopic surveillance. Local unsalvageable disease was rare. In OPRA (2022), patients received total neoadjuvant therapy and response-based surgery or watch-and-wait. Three-year TME-free survival was 41% after induction chemotherapy then chemoradiotherapy versus 53% after chemoradiotherapy then consolidation chemotherapy. Three-year disease-free survival was 76% in each arm, compared with a 75% historical benchmark.
Extension

Follow-up studies, subgroup analyses, and real-world validation

Updated OPRA results had a median follow-up of 5.1 years. Five-year TME-free survival was 39% after induction chemotherapy then CRT and 54% after CRT then consolidation chemotherapy. Of 81 patients with regrowth, 94% occurred within 2 years and 99% within 3 years. DFS was similar after TME at restaging and after TME for regrowth. IWWD also found that regrowth was usually early and in the bowel wall, emphasizing endoscopic surveillance to preserve the option of deferred curative surgery.
Guidelines

Integration into clinical practice guidelines and recommendations

OPRA studied total neoadjuvant therapy followed by response-based surgery or watch-and-wait.
Now

Current standard of care and ongoing research directions

Watch-and-wait studies concern selected responders after neoadjuvant therapy. IWWD analyzed complete clinical responders; updated OPRA offered watch-and-wait after complete or near-complete response to total neoadjuvant therapy. Regrowth was usually early, supporting continued surveillance rather than assuming safety is settled. Questions remain about AI-enhanced MRI for response prediction, circulating tumor DNA for regrowth detection, surveillance schedules and patient selection.

Landmark Trials in This Story

Explore the evidence yourself

Ask AttendMe about any trial, guideline, or clinical question. Evidence-ranked answers from 3.7M+ peer-reviewed articles.

Frequently Asked Questions

What is the watch-and-wait approach for rectal cancer?+
Watch-and-wait offers selected clinical complete responders surveillance instead of immediate resection. Habr-Gama reported nonoperative outcomes in 71 complete clinical responders. IWWD identified 1009 patients from 47 institutes and analyzed 880 with complete clinical response. OPRA randomized 324 patients to treatment sequences, then selected surgery or watch-and-wait by response. Three-year TME-free survival was 41% with induction chemotherapy then CRT and 53% with CRT then consolidation chemotherapy.
What happens if the cancer regrows during watch-and-wait?+
Based on IWWD data, local regrowth occurs predominantly within the first 2 years and is typically confined to the bowel wall. IWWD reported that local unsalvageable disease was rare. OPRA reported similar disease-free survival after TME at restaging and after TME for regrowth.

Medical Disclaimer: This content is for educational purposes only and does not constitute medical advice. Clinical decisions should always be based on individual patient assessment, local guidelines, and professional judgement.

All data sourced from published, peer-reviewed articles and clinical practice guidelines.

Claims checked against cited sources: 10 November 2026